Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta, Collaborators Report on microRNAs in Epithelial-Mesenchymal Transition


Rosetta Genomics this week announced the publication of data demonstrating the involvement of certain microRNAs in epithelial-mesenchymal transition, or EMT, in cancers of unknown primary origin.

EMT is the acquisition of migratory, mesenchymal-like properties of epithelial cells, and is often associated with cancer metastasis.

According to the data, which appeared in Clinical & Translational Oncology, Rosetta and collaborators from the University of Ioannina studied the expression of 982 miRNAs in 68 cases of cancer of unknown primary origin.

They found that miR-203 and members of the miR-200 family were "consistently but non-significantly downregulated" in such cancers with the EMT phenotype.

"In view of the consistency of the observed levels of miR200 family expression by EMT status, more sensitive EMT-capturing technologies and larger [cancer of unknown primary origin] cohorts should be studied for further validation of these data," study co-author George Pentheroudakis said in a statement.

Rosetta currently markets an miRNA-based diagnostic for determining the source of cancers of unknown primary origin called the Rosetta Cancer Origin test.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.